+36.1%
MRNA vs EQX
+168.9%
-132.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EQX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.6% | +3.7% | +4.8% |
| 7D | -1.1% | -3.2% | +2.1% | 0.0% |
| 30D | +126.1% | +7.8% | +118.4% | +124.0% |
| 3M | +190.0% | +21.3% | +168.7% | +181.8% |
| 6M | +157.2% | -22.4% | +179.6% | +161.0% |
| YTD | +388.2% | -11.3% | +399.5% | +388.7% |
| 1Y | +467.0% | +13.5% | +453.5% | +457.4% |
| 3Y | +36.1% | +162.1% | -126.1% | +26.9% |
| All | +36.1% | +168.9% | -132.9% | +26.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EQX.
Daily Out/Under-Performance
Portfolio return minus EQX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EQX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling